Public funding enabled early proof-of-concept studies that leveraged patents and prototypes, fostering a virtuous cycle of collaboration involving academia, industry and people receiving treatment, culminating in DBS implants.
In the UK, a patent grants exclusive rights to an invention, but only if it meets specific criteria, such as being new, original, and useful.